- You are here: Home
- Disease Models
- Infectious Disease Models
Disease Models
- Oncology Models
-
Inflammation & Autoimmune Disease Models
- Rheumatoid Arthritis Models
- Glomerulonephritis Models
- Multiple Sclerosis (MS) Models
- Ocular Inflammation Models
- Sjögren's Syndrome Model
- LPS-induced Acute Lung Injury Model
- Peritonitis Models
- Passive Cutaneous Anaphylaxis Model
- Delayed-Type Hypersensitivity (DTH) Models
- Inflammatory Bowel Disease Models
- Systemic Lupus Erythematosus Animal Models
- Asthma Model
- Sepsis Model
- Psoriasis Model
- Atopic Dermatitis (AD) Model
- Scleroderma Model
- Gouty Arthritis Model
- Carrageenan-Induced Air Pouch Synovitis Model
- Carrageenan-Induced Paw Edema Model
- Experimental Autoimmune Myasthenia Gravis (EAMG) Model
- Cardiovascular Disease Models
-
Neurological Disease Models
- Alzheimer's Disease Modeling and Assays
- Seizure Models
- Parkinson's Disease Models
- Ischemic Stroke Models
- Acute Spinal Cord Injury (ASCI) Model
- Traumatic Brain Injury (TBI) Model
- Hypoxic-Ischemic Encephalopathy (HIE) Model
- Tourette Syndrome (TS) Model
- Amyotrophic Lateral Sclerosis (ALS) Model
- Huntington's Disease (HD) Model
- Intracerebral hemorrhage (ICH) Models
- Pain Models
- Metabolic Disease Models
- Liver Disease Models
- Rare Disease Models
- Respiratory Disease Models
- Digestive Disease Models
-
Urology Disease Models
- Cisplatin-induced Nephrotoxicity Model
- Unilateral Ureteral Obstruction Model
- 5/6 Nephrectomy Model
- Renal Ischemia-Reperfusion Injury (RIRI) Model
- Diabetic Nephropathy (DN) Models
- Passive Heymann Nephritis (PHN) Model
- Adenine-Induced Chronic Kidney Disease (CKD) Model
- Kidney Stone Model
- Doxorubicin-Induced Nephropathy Model
- Orthopedic Disease Models
- Ocular Disease Models
Infectious Disease Models
Animal models play a crucial role in drug development, acting as an essential bridge between in vitro studies and human clinical trials. Creative Bioarray leads the way in bioresearch, offering an extensive range of infectious disease models specifically designed for the development of cutting-edge antimicrobial, antiviral, and vaccine candidates. These sophisticated models are invaluable tools for advancing novel anti-infective therapies. They allow researchers to rigorously assess the efficacy, safety, and pharmacokinetics of promising antiviral compounds within a controlled environment, all before transitioning into human clinical trials. Discover how Creative Bioarray's innovative approach and comprehensive suite of models can revolutionize your research and expedite the path to clinical success.
Types of Our Infectious Disease Models
Given the persistent global burden of infectious diseases, there is a clear and acute need for continued research and development of novel intervention methods targeting viral, bacterial and fungal infections. Creative Bioarray has extensive experience with a variety of these models and operates a fully equipped BSL-2 and ABSL-2 facility to support pre-clinical projects.
Anti-infective Drug Study Endpoints
- Survival rate
- Microbial counts
- Histopathology
- Cytokine analysis
- Hematology analysis
- qPCR or Western blot
- Other customized endpoints according to your specific needs
Quotation and Ordering
Creative Bioarray boasts a robust and comprehensive drug discovery program focused on infectious diseases. Our platform is dedicated to the identification and evaluation of innovative antimicrobial, antiviral, and vaccine candidates, utilizing well-established in vivo models. With our in-house expertise, we collaborate closely with our clients to meticulously design experiments that effectively assess the efficacy of anti-infective agents. If you are interested in our services, please do not hesitate to contact us at any time or submit an inquiry to us directly.
For research use only. Not for any other purpose.
